AKTS Technical Analysis & Stock Price Forecast

Technical Sentiment

Overall Consensus

Sell

Buy

Technical Analysis Consensus

Sell

Buy

Moving Average Consensus

Sell

Buy

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.749, suggesting AKTS is Strong Sell.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 18.646, while Aktis Oncology Inc (AKTS) share price is $16.54, making it Sell.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.444, while Aktis Oncology Inc (AKTS) share price is $16.54, making it Sell.

Technical Analysis for AKTS

Technical Sentiment Analysis for Aktis Oncology Inc (AKTS) As of 2026-03-30, Aktis Oncology Inc (AKTS) is exhibiting a Strong Sell technical sentiment. Our proprietary analysis, which aggregates 12 technical signals, shows that 3 indicators are flashing buy, while 9 are indicating sell.

Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for AKTS stands at 39.256, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at -0.749, providing a Sell signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 18.367 and the Commodity Channel Index (CCI) at -201.938 further confirm a -3.23 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, AKTS is trading below its 60-day moving average of $19.444 and below its 200-day long-term moving average of $19.444. Key price levels to watch include the immediate resistance at $20.486 and strong support at $14.916. A break above $20.486 could signal a bull continuation, while falling below $14.916 may test the next Fibonacci floor at $12.033.

Aktis Oncology Inc (AKTS) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	9.346	12.033	14.916	17.603	20.486	23.173	26.056
Fibonacci	12.033	14.161	15.475	17.603	19.731	21.045	23.173

Aktis Oncology Inc (AKTS) Technical Indicators

2026-03-30

Name	Value
RSI_14	39.256
STOCHk_14_3_3	18.367
STOCHd_14_3_3	25.38
CCI_20	-201.938
AO_5_34	-1.426
MOM_10	-3.23
MACD_12_26_9	-0.749

Aktis Oncology Inc (AKTS) Relative Strength Index (RSI) is 39.256, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Stochastic Oscillator is 18.367, creating a Buy signal.

Aktis Oncology Inc (AKTS) Stochastic RSI is 25.38, creating a Neutral signal.

Aktis Oncology Inc (AKTS) Commodity Channel Index (CCI) is -201.938, creating a Buy signal.

Aktis Oncology Inc (AKTS) Awesome Oscillator is -1.426, creating a Sell signal.

Aktis Oncology Inc (AKTS) Momentum is -3.23, creating a Sell signal.

Aktis Oncology Inc (AKTS) MACD is -0.749, creating a Sell signal.

Aktis Oncology Inc (AKTS) Moving Average

2026-03-30

Period	Simple	Signal
MA_5	17.324	Sell
MA_10	17.799	Sell
MA_20	18.646	Sell
MA_60	19.444	Sell
MA_200	19.444	Sell
MA_250	19.444	Sell

Aktis Oncology Inc (AKTS) 5-Day simple moving average is 17.324, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

Aktis Oncology Inc (AKTS) 10-Day simple moving average is 17.799, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

Aktis Oncology Inc (AKTS) 20-Day simple moving average is 18.646, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

Aktis Oncology Inc (AKTS) 60-Day simple moving average is 19.444, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

Aktis Oncology Inc (AKTS) 200-Day simple moving average is 19.444, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

Aktis Oncology Inc (AKTS) 250-Day simple moving average is 19.444, while Aktis Oncology Inc (AKTS) share price is $16.54, making it a Sell.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for AKTS?

The overall technical consensus for Aktis Oncology Inc (AKTS) is currently Strong Sell. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 3 sell signals.

What are the key support and resistance levels for Aktis Oncology Inc (AKTS) today?

Based on pivot point calculations, Aktis Oncology Inc (AKTS) has an immediate support level at 14.916 and a major resistance level at 20.486. Traders also monitor the pivot point at 17.603 to determine the intraday trend direction.

Is Aktis Oncology Inc (AKTS) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Aktis Oncology Inc (AKTS) is currently 39.256. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Aktis Oncology Inc (AKTS)?

Aktis Oncology Inc (AKTS) Moving Averages Convergence Divergence (MACD) indicator is -0.749, suggesting AKTS is Strong Sell. This indicator helps identify potential trend reversals or momentum shifts for Aktis Oncology Inc.

How is Aktis Oncology Inc (AKTS) performing relative to its 200-day moving average?

Aktis Oncology Inc (AKTS) is currently trading at $16.54, which is below its 200-day simple moving average of 19.444. Trading below the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.